Morse Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$956K Sell
2,358
-300
-11% -$122K 0.21% 94
2025
Q1
$1.32M Sell
2,658
-129
-5% -$64.2K 0.33% 66
2024
Q4
$1.45M Sell
2,787
-9,039
-76% -$4.7M 0.33% 69
2024
Q3
$7.32M Sell
11,826
-172
-1% -$106K 1.58% 17
2024
Q2
$6.64M Sell
11,998
-1,114
-8% -$616K 1.61% 18
2024
Q1
$7.62M Buy
13,112
+259
+2% +$151K 1.94% 12
2023
Q4
$6.82M Sell
12,853
-474
-4% -$252K 2.01% 14
2023
Q3
$6.75M Buy
13,327
+166
+1% +$84K 2.13% 12
2023
Q2
$6.87M Buy
13,161
+557
+4% +$291K 2.09% 11
2023
Q1
$7.27M Buy
12,604
+113
+0.9% +$65.1K 2.45% 7
2022
Q4
$6.88M Sell
12,491
-81
-0.6% -$44.6K 2.5% 9
2022
Q3
$6.38M Sell
12,572
-603
-5% -$306K 2.41% 9
2022
Q2
$7.16M Buy
13,175
+339
+3% +$184K 2.3% 8
2022
Q1
$7.58M Sell
12,836
-5,097
-28% -$3.01M 1.88% 10
2021
Q4
$12M Buy
17,933
+21
+0.1% +$14K 2.67% 6
2021
Q3
$10.2M Buy
17,912
+306
+2% +$175K 2.44% 9
2021
Q2
$8.88M Sell
17,606
-716
-4% -$361K 2.15% 10
2021
Q1
$8.36M Buy
18,322
+728
+4% +$332K 2.15% 10
2020
Q4
$8.2M Sell
17,594
-473
-3% -$220K 2.27% 12
2020
Q3
$7.98M Sell
18,067
-850
-4% -$375K 2.56% 10
2020
Q2
$6.85M Buy
18,917
+1,905
+11% +$690K 2.44% 11
2020
Q1
$4.83M Buy
17,012
+622
+4% +$176K 2.3% 14
2019
Q4
$5.33M Buy
16,390
+365
+2% +$119K 1.83% 14
2019
Q3
$4.67M Sell
16,025
-2,725
-15% -$794K 1.74% 16
2019
Q2
$5.51M Sell
18,750
-379
-2% -$111K 1.62% 19
2019
Q1
$5.24M Buy
19,129
+3,650
+24% +$999K 1.57% 18
2018
Q4
$3.46M Buy
15,479
+2,905
+23% +$650K 1.23% 26
2018
Q3
$3.07M Buy
12,574
+7,830
+165% +$1.91M 0.81% 39
2018
Q2
$983K Buy
4,744
+3,455
+268% +$716K 0.27% 84
2018
Q1
$266K Buy
1,289
+75
+6% +$15.5K 0.07% 130
2017
Q4
$231K Buy
1,214
+120
+11% +$22.8K 0.06% 125
2017
Q3
$207K Buy
+1,094
New +$207K 0.06% 124